$ Value
—
Shares
36,557,141
Price
—
Filed
Feb 10
Insider
Name
Elcan Patricia F
Title
—
CIK
0001433376
Roles
Transaction Details
Transaction Date
2026-02-06
Code
J
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
36,557,141
Footnotes
On February 6, 2026, Frisco ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. | Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of her pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,971,002 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee. | These Shares are held jointly with the Reporting Person's spouse. | Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of her pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 404,512 Shares by the Reporting Person; 84,306 Shares by the Reporting Person's spouse; and 9,785,498 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee. | These Shares are held by trusts for the benefit of the Reporting Person's children of which the Reporting Person or her spouse is trustee.
Filing Info
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |